All News

REMOXY ER is an abuse-deterrent, oral formulation of the widely prescribed opioid medication oxycodone.

The FDA voted against recommendign oxycodone extended-release capsules (REMOXY ER, Pain Therapeutics) for approval for the management of pain severe enough to require long-term, around-the-clock opioid treatment, during a joint meeting of the agency’s Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC), and the Drug Safety and Risk Management Advisory Committee (DSARM).

The FDA has granted approval to Array BioPharma’s encorafenib (Braftovi) capsules in combination with binimetinib (Mektovi) tablets for the treatment of patients with unresectable or metastatic melanoma with BRAFV600E or BRAFV600K mutation.

Encorafenib (Braftovi) and binimetinib (Mektovi) is now available for patients with advanced BRAF-mutant melanoma.

Researchers identified a trend in which higher body mass index was associated with lower breast cancer risk in women before menopause.

Food allergens can be present in a variety of medications, but they don't always merit a switch in therapy.

African Americans are more likely to be diagnosed with HIV compared with other groups, according to an analysis published in the Journal of Racial and Ethnic Health Disparities.

Top news of the day from across the health care landscape

Although HIV diagnoses have dropped across every population in the United States, African Americans remain disproportionately affected by HIV.

Top news of the day from across the health care landscape

Mortality from opioids may be higher than it appears.

National HIV Testing Day, designated by the CDC, aims to encourage individuals to know their status.

Carl Grunfeld, MD, PhD, explains the importance of pharmacists in treating patients with diabetes and HIV, and how they can help them manage these conditions better.

Rachele Berria, MD, PhD, Vice President and Head of the Diabetes Medical Unit at Sanofi, explains the role of pharmacists in helping patients manage their diabetes.

The CDC designated Wednesday, June 27 as National HIV Testing Day, to raise awareness for HIV infection testing, and early diagnosis.

Carl Grunfeld, MD, PhD, from the University of California San Francisco School of Medicine discusses what lifestyle modifications patients can make to manage their HIV and Diabetes.

Ronnie Aronson, MD, FRCPC, FACE, Medical Director of LMC Diabetes and Endocrinology, discusses the key role pharmacists play in treating patients with CGM systems.

This medication represents a new treatment for patients with cUTI, including pyelonephritis, due to certain Enterobacteriaceae.

New data demonstrate that evolocumab (Repatha) significantly reduced low-density lipoprotein cholesterol and non-high density lipoprotein cholesterol in patients with type 2 diabetes plus hypercholesterolemia or mixed dyslipidemia.

A novel epigenetic drug can be combined with an existing therapy, venetoclax, to more effectively kill high-risk neuroblastoma cells.

The FDA has approved a cannabidiol (CBD) treatment for 2 rare and severe forms of epilepsy, making it the first FDA-approved medication that contains a purified drug substance derived from marijuana.

Top news of the day from across the health care landscape

Top news of the day from across the health care landscape

Elotuzumab with pomalidomide and low-dose dexamethasone met its primary endpoint in showing a statistically significant, clinically meaningful improvement in progression-free survival in patients with relapsed/refractory multiple myeloma.

Officials with the FDA have approved plazomicin (Zemdri, Achaogen) for the treatment of adults with complicated urinary tract infections (cUTIs), caused by certain Enterobacteriaceae, in patients with limited or no alternative treatment.

Discover nine overlapping eating habits and lifestyle practices that can help create a healthier, happier, and longer life.

Officials with the FDA have approved cannabidiol oral solution (Epidiolex) for the treatment of seizures associated with 2 rare and severe forms of epilepsy, Lennox-Gastaut syndrome, and Dravet syndrome, in patients aged 2 years and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana, and is the first FDA approval of a drug for the treatment of patients with Dravet syndrome.

Epidiolex is the first FDA-approved drug that contains an active ingredient derived from marijuana and is the first approved treatment for patients with Dravet syndrome.

Pharmacists can provide preconception care within their scope of practice as part of routine health care to women and men of reproductive potential, regardless of pregnancy intention

Newly published findings from the PIONEER 1 phase 3a trial show that once-daily once-daily oral semaglutide was associated with significant reductions in blood sugar in adults with type 2 diabetes.